Related Experiment Videos
Opsonizing antibodies against pneumococci detected by enhanced NBT. Reduction of phagocytizing granulocytes
Abstract:
Specific opsonizing antibodies against pneumococci were demonstrated in serum by measuring their effect on the nitroblue tetrazolium (NBT) reduction of normal human granulocytes. In comparison to normal serum, convalescent sera from patients with severe pneumococcal disease caused a significant enhancement in NBT reduction in the presence of homologous antigen. Enhanced NBT reduction was observed in 24 of the 26 sera tested and was further increased by complement. The reaction was mainly type-specific, although a few cross-reactions did occur. A dose-response effect was observed when sera were tested in two-fold dilutions. The enhancement in NBT reduction could be partially eliminated by the absorption of sera with homologous antigens. The appearance and subsequent increase in opsonizing antibodies was observed in consecutive samples from one patient. This method can be useful in the study of immunological responses to pneumococcal vaccine or disease, since it measures antibodies which are essential for immune defence.
Insights
This study demonstrates a new method to detect specific opsonizing antibodies against pneumococci in patient serum using nitroblue tetrazolium (NBT) reduction. This technique shows promise for evaluating immune responses to pneumococcal disease and vaccines.
Area of Science:
- Immunology
- Microbiology
- Clinical Chemistry
Background:
- Opsonizing antibodies are crucial for effective immune defense against bacterial infections like pneumococcal disease.
- Accurate measurement of these antibodies is essential for understanding immune responses and vaccine efficacy.
Purpose of the Study:
- To develop and validate a novel method for detecting specific pneumococcal opsonizing antibodies in human serum.
- To assess the utility of nitroblue tetrazolium (NBT) reduction by granulocytes as an indicator of antibody presence and function.
Main Methods:
- Serum samples were analyzed for their ability to enhance the NBT reduction of normal human granulocytes in the presence of pneumococcal antigens.
- The effect of complement and antigen specificity on NBT reduction was investigated.
- Dose-response and absorption studies were performed to characterize the antibody detection assay.
Main Results:
- Convalescent sera from patients with severe pneumococcal disease significantly enhanced NBT reduction compared to normal serum.
- Enhanced NBT reduction was observed in 24 out of 26 sera tested, indicating the presence of specific opsonizing antibodies.
- The reaction demonstrated primarily type-specificity, with some cross-reactivity observed, and showed a clear dose-response relationship.
Conclusions:
- The NBT reduction assay effectively detects specific opsonizing antibodies against pneumococci in human serum.
- This method provides a valuable tool for studying immunological responses to pneumococcal infections and the efficacy of pneumococcal vaccines.
- The assay's sensitivity to antibody levels and specificity highlights its potential clinical and research applications.